Diabetes has become a major global health epidemic that is characterised by high blood sugar levels and the leading cause of mortality. The World Health Organization (WHO) estimated that 8.5% of individuals had diabetes in 2014. A person with diabetes either cannot create enough insulin (type 1 diabetes), cannot manufacture enough insulin, or cannot efficiently use the body’s produced insulin (type 2 diabetes).
Gestational diabetes is a different type of diabetes that can affect pregnant women. Although gestational diabetes normally goes away after birth, it might eventually progress to type 2 diabetes in women. The majority of continuous glucose monitoring systems need the use of needles, which increases the risk of infection. The invasive glucose monitoring device also Furthermore, the invasive glucose monitoring device is considered to be discrete glucose measurement system which cannot be practically used for continuous monitoring of blood glucose.
Request a Sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-2613
Nevertheless, because some signs of hyperglycemia between measures are not recorded, the blood glucose pattern is inaccurate or not represented at all. Noninvasive glucose monitoring reduces the need for painful finger pricking, which increases the risk of infection and the amount of tissue damage done to the finger.
As a result, non-invasive continuous glucose monitoring devices have received a lot of attention over the past few years due to their potential to continually test glucose under tightly controlled (such as in-clinic) circumstances. Near infrared spectroscopy (NIRS), mid-infrared spectroscopy (Mid-IRS), Raman spectroscopy, photoacoustic spectroscopy (PA), optical coherence tomography (OCT), and many other techniques are used to test blood glucose levels non-invasively.
Non- Invasive Blood Glucose Monitoring Devices Market: Drivers & Restraints
It is anticipated that as the prevalence of diabetes increases worldwide, more people will use noninvasive blood glucose monitoring devices. The market for non-invasive blood glucose monitoring devices is anticipated to grow at a faster rate during the forecast period due to the numerous drawbacks associated with the use of invasive blood glucose monitors and the growing need to develop noninvasive glucose monitoring diagnostic techniques.
For instance, in June 2015, researchers in the UK created a blood glucose gadget that measures blood glucose levels on the skin surface using low-powered lasers. Also, a bench-top version of the device is undergoing clinical trials investigations and might hit the market in the upcoming years.
This includes, a finger-touch device similar to a computer mouse and a wearable version for continuous blood glucose monitoring. In addition, increasing efforts by several startup manufacturers, for example, Prediktor Medical- a Norway based manufacturer is developing a wearable device for estimation of blood glucose levels based on the combination of several principles determining the noninvasive glucose monitoring including, advanced multivariate analysis and dynamic models for insulin or glucose interaction.
The gadget is anticipated to take the shape of a watch or bracelet that communicates with a tablet or mobile phone to display data. Patients would be able to continuously check their blood sugar levels without the need for an implant thanks to this. Due to the significant physical and chemical interference, currently existing blood glucose measurement instruments lack specificity and sensitivity.
Ask for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-2613
Multivariate regression analyses are used by non-invasive glucose monitoring systems to transform optical data to glucose levels. So, the gadget should be made so that it accurately detects blood glucose levels, which is essential for the best possible treatment and disease management.
Non- Invasive Blood Glucose Monitoring Devices Market: Overview
Diabetes is becoming more prevalent worldwide, which has serious economic ramifications for the individual. It is estimated that 350 million individuals worldwide currently suffer with diabetes. Therefore, it is crucial to continuously monitor blood glucose levels to manage the current, large population of people with diabetes.
Manufacturers are concentrating on creating diagnostic methods that are highly trustworthy and monitor people’s blood glucose levels more accurately, with the potential to enhance glycemic control and patient wellbeing.
Noninvasive blood glucose monitors are providing enormous opportunity for all the device manufacturers, patients, and various healthcare professionals throughout the world by integrating sensing components, electronics, and a dependable power source in a single unit. Increased regulatory approval times for blood glucose monitors are a significant element that will also contribute to higher sales of noninvasive blood glucose devices throughout the projection period.
Non- Invasive Blood Glucose Monitoring Devices Market: Region-wise Outlook
The market for non-invasive blood glucose monitoring devices is divided into seven major geographic areas based on their presence: North America, Latin America, Eastern Europe, Western Europe, Asia pacific outside of Japan, Japan, the Middle East, and Africa.
The main factor driving the use of noninvasive blood glucose monitoring systems is the rising diabetic population in the United States. According to the Centers for Disease Control and Prevention, 29.1 million Americans have diabetes. According to the research, adults with diabetes have a 50% increased risk of dying.
Furthermore, growing need of continuous non-invasive method of blood glucose diagnosis among patients is expected to create higher demand for noninvasive blood glucose monitoring systems worldwide. The incidence of diabetes is higher in regions such as Asia Pacific, North America and Western Europe. Presence of several pipeline blood glucose monitoring systems and their expected launch is expected to drive the market for noninvasive blood glucose devices over the forecast period.
Non- Invasive Blood Glucose Monitoring Devices Market: Key Players
Some of the key market players in the non- invasive blood glucose monitoring devices market are, Abbott, Animas Technologies, Bayer Healthcare, Cercacor, Pendragon Medical, OrSense, and Bayer Healthcare.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Market Size
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, N. Africa)
Ask An Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-2613
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Non- Invasive Blood Glucose Monitoring Devices Market: Segmentation
Non- invasive blood glucose monitoring devices marketis segmented by technology, modality end user and geography:
By Technology
- MIR/NIR (Mid/Near Infrared Spectroscopy)
- Raman Spectroscopy
- Occlusion Spectroscopy
- Optical Coherence Tomography
- Thermal Emission Spectroscopy
- Photoacoustic Spectroscopy
- Impedance/Dielectric Spectroscopy
- Electromagnetic
- Polarimetry
- Fluorescence
By Modality
- Wearable Blood Glucose Monitoring Systems
- Non-wearable /Table top Blood Glucose Monitoring Systems
By End User
- Hospitals
- Home Care Settings
- Clinics
- December 2022
- REP-GB-2613
- Upcoming
- Healthcare
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
